English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Since there is not a definite cause for Kienbock's diseases despite appropriate knowledge of lunate bone blood supply, so there is a great debate about the ideal treatment protocol for treatment of Kienbock's diseases. Objective: The aim of this study is to assess outcome of combining distal capitate shortening and fusion to the base of the third metacarpal bone for treatment of Kienbock's disease (Lichtman stage II or stage IIIA) with neutral ulna variance. Methods: Twenty patients with 20 consecutive Kienbock's disease, their age mean was 26.1(SD 5.6) y. Patients were evaluated radiologically and clinically including pre- and post-operatively for pain, (ROM) and grip strength. Functional evaluation was carried out using (MMWS). Results: The final post-operative (MMWS) showed increasing from 17 (SD 2.5) to 88.5 (SD7.3). Conclusion: The technique of distal capitate shortening with capito-metacarpal fusion yielded satisfactory results especially for treatment of stage II, than in stage IIIA.

Kienböck's Diseases Treatment. A Novel Technique via Distal Capitate Shortening Accompanied by 3rd Metacarpal Base Fusion in Neutral Variance Ulna